Active Surveillance | Radical Prostatectomy | Radiotherapy | Cryotherapy | Primary Androgen Deprivation Therapy | |
---|---|---|---|---|---|
% | |||||
Low | 9.2% | 56.8% | 23.3% | 3.1% | 7.6% |
Intermediate | 4.8% | 52.9% | 25.8% | 4.5% | 11.9% |
High | 3.2% | 32.2% | 25.6% | 6.1% | 32.8% |
Unknown | 9.9% | 42.2% | 26.3% | 2.6% | 18.9% |
N | |||||
Low | 5 | 28 | 11 | 2 | 4 |
Intermediate | 2 | 26 | 13 | 2 | 6 |
High | 1 | 6 | 5 | 1 | 7 |
Unknown | 2 | 7 | 4 | 0 | 3 |
Total | 10 | 67 | 33 | 5 | 20 |
Total cost by treatment as a percentage of total cost of screening and treatment | 31.3% | 32.0% | |||
Complication rate | 17.0% | 1.6% | |||
Total complication cost by treatment as a percentage of total cost of screening and treatment | 10.4% | 0.11% | |||
Total treatment cost as a percentage of total screening and treatment cost | 66.6% |